Hung IF, Lung KC, Tso EY, Liu R, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 2020 May 8. pii: S0140-6736(20)31042.
PMID: 32401715